Mackenzie Financial Corp Puma Biotechnology, Inc. Transaction History

Mackenzie Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.64 - $3.3 $3,401 - $6,844	-2,074 Reduced 17.05%	10,090 $29,000
Q1 2022 May 13, 2022	BUY	$2.13 - $3.24 $25,909 - $39,411	12,164 New	12,164 $35,000
Q4 2020 Feb 10, 2021	SELL	$7.78 - $12.13 $301,397 - $469,916	-38,740 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$9.5 - $11.14 $368,030 - $431,563	38,740 New	38,740 $391,000

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $128M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.